This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

The Early Nasojejunal Tube to Meet Energy Requirements in Intensive Care (ENTERIC) Study (ENTERIC)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2005 by Bayside Health.
Recruitment status was:  Not yet recruiting
Information provided by:
Bayside Health Identifier:
First received: September 12, 2005
Last updated: February 23, 2007
Last verified: August 2005
This is a multi-centre randomised controlled trial comparing early jejunal feeding (using a frictional nasojejunal [NJ] tube) and standard feeding in critical illness.

Condition Intervention
Critical Illness Malabsorption Syndromes Procedure: Early jejunal feeding (using frictional NJ tube) Procedure: Standard feeding (using nasogastric [NG] tube)

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: The Early Nasojejunal Tube to Meet Energy Requirements in Intensive Care Study

Further study details as provided by Bayside Health:

Primary Outcome Measures:
  • The amount of EN delivered during the Intensive Care Unit (ICU) stay

Secondary Outcome Measures:
  • Amount of EN delivered during the first 10 days of the study
  • Daily cumulative proportion of EN delivered
  • Ventilator-associated pneumonia rate
  • Duration of mechanical ventilation
  • Duration of hospitalisation
  • Mortality at hospital discharge
  • Success rate of placement into both the small bowel, generally, and the jejunum, specifically
  • Complication rates (as compared to the nasogastric tube)

Estimated Enrollment: 180

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

ICU patients are eligible for enrolment if they meet all of the following:

  • Age > 18 years old
  • In ICU for < 48 hours prior to enrolment
  • Receiving invasive mechanical ventilation (through an endotracheal tube or tracheostomy, but NOT a facemask) with an anticipated need for > 48 hours of mechanical ventilation
  • Receiving a continuous infusion of any one of:

    • morphine > 2 mg/hour,
    • fentanyl > 20 mcg/hour, or
    • pethidine > 20 mg/hour
  • Either a single GRV > 150 mls (whilst receiving EN via a NG tube) or nasogastric drainage > 500 mls over 12 hours (whether receiving EN or not)

Exclusion Criteria:

Patients will be ineligible for enrolment if they meet any of the following:

  • Previous or recent surgery which has altered the anatomy of the upper gastrointestinal tract (eg. oesophagectomy, gastrectomy, any gastric anastomosis surgery, gastroplasty, pyloroplasty, pancreaticoduodenectomy [Whipple’s procedure])
  • Known gastric malignancy
  • Known oesophageal varices
  • Current admission for peptic ulceration
  • Current mechanical bowel obstruction
  • Current gastrostomy, jejunostomy, or surgically-placed enteral tube in situ
  • Contraindication to the use of the nose and mouth for enteral tube insertion (eg. recent facial trauma or surgery)
  • Receiving nutritional support prior to ICU admission
  • Severe coagulopathy (defined by platelet count < 20 and/or international normalized ratio [INR] > 4.0)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00163813

Contact: Andrew Davies +61 3 92762607
Contact: Siouxzy Morrison 92071343

Australia, Victoria
Alfred Hospital Not yet recruiting
Melbourne, Victoria, Australia, 3181
Contact: Siouxzy Morrison    92071343   
Sponsors and Collaborators
Bayside Health
Principal Investigator: Andrew Davies The Alfred
  More Information Identifier: NCT00163813     History of Changes
Other Study ID Numbers: 232/04
Study First Received: September 12, 2005
Last Updated: February 23, 2007

Keywords provided by Bayside Health:
medical-surgical critically ill patients
reduced gastric motility

Additional relevant MeSH terms:
Critical Illness
Malabsorption Syndromes
Disease Attributes
Pathologic Processes
Intestinal Diseases
Gastrointestinal Diseases
Digestive System Diseases
Metabolic Diseases processed this record on September 21, 2017